Back to results
US 2016/0250231 A1Published application
Solid drug implants for intracochlear delivery of therapeutics for the treatment of otic disorders
AssigneeO-Ray Pharma, Inc.
InventorsWilliam H. Slattery, Thomas Smith, Erik Pierstorff, Marc M. Baum
Life of this patent
Estimating the term…
Abstract
The present invention provides for pharmaceutical preparations, devices, systems and methods for the treatment of otic diseases and conditions. In various embodiments, the preparations, devices, systems and methods enable sustained drug release for the treatment or prevention of hearing loss, infections, and other pathological conditions of cochlea and inner ear.
Claims45
A method, comprising:
- providing a pharmaceutical preparation for sustained-release of an active pharmaceutical ingredient (API) after cochlear administration or implantation, comprising:
- one or more core particles adapted for administration or implantation into the cochlea, wherein each core particle comprises the API, wherein the pharmaceutical preparation is not in a liquid suspension;
- and
- administering or implanting into the cochlea the pharmaceutical preparation to provide sustained-release administration of the API.
1 more element
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
45-91. (canceled)
Dependencies are inferred from the claim text.